Cite
Leveraging molecular biomarkers to make the common diagnosis in the uncommon patient.
MLA
Day, Gregory S., et al. “Leveraging Molecular Biomarkers to Make the Common Diagnosis in the Uncommon Patient.” Journal of Neuroimmunology, vol. 352, Mar. 2021, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.jneuroim.2021.577474.
APA
Day, G. S., Gordon, B. A., Bucelli, R. C., Perrin, R. J., Lopez-Chiriboga, A. S., & Ances, B. M. (2021). Leveraging molecular biomarkers to make the common diagnosis in the uncommon patient. Journal of Neuroimmunology, 352, N.PAG. https://doi.org/10.1016/j.jneuroim.2021.577474
Chicago
Day, Gregory S., Brian A. Gordon, Robert C. Bucelli, Richard J. Perrin, A. Sebastian Lopez-Chiriboga, and Beau M. Ances. 2021. “Leveraging Molecular Biomarkers to Make the Common Diagnosis in the Uncommon Patient.” Journal of Neuroimmunology 352 (March): N.PAG. doi:10.1016/j.jneuroim.2021.577474.